An unusual presentation of Juvenile-onset systemic lupus erythematosus: Budd–Chiari syndrome with secondary antiphospholipid syndrome and lupus nephritis: a case report
Open Access
- 3 November 2026
- journal article
- case report
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 53 (1) , 89
Abstract
Background: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease affecting young women. Budd–Chiari syndrome (BCS), caused by hepatic venous outflow obstruction, is a rare manifestation often associated with secondary antiphospholipid syndrome (APS). Case summary: A 17-year-old girl presented with progressive abdominal distension, pedal edema, fever, weight loss, arthralgia, oral ulcers, alopecia, and amenorrhea. Initially managed as chronic liver disease after recurrent presumed spontaneous bacterial peritonitis, imaging revealed chronic BCS. Further evaluation demonstrated positive antinuclear and anti-double-stranded DNA antibodies, hypocomplementemia, proteinuria, and Class IV lupus nephritis. Persistent antiphospholipid antibody positivity confirmed secondary APS. Treatment with corticosteroids, mycophenolate mofetil, hydroxychloroquine, and planned indefinite anticoagulation resulted in marked clinical improvement. Conclusion: SLE with secondary APS should be considered in young women presenting with unexplained BCS to enable early diagnosis, prompt immunosuppressive therapy, and prevention of irreversible organ damage.Keywords
This publication has 14 references indexed in Scilit:
- Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicityLupus Science & Medicine, 2026
- 2023 ACR/EULAR antiphospholipid syndrome classification criteriaAnnals of the Rheumatic Diseases, 2023
- Budd–Chiari Syndrome as an Initial Presentation of Systemic Lupus Erythematosus Associated with Antiphospholipid Syndrome: A Case Report with Review of the LiteratureOpen Access Rheumatology: Research and Reviews, 2023
- Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohortLupus, 2021
- Type I interferon in the pathogenesis of systemic lupus erythematosusCurrent Opinion in Immunology, 2020
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritisAnnals of the Rheumatic Diseases, 2020
- European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiativeAnnals of the Rheumatic Diseases, 2017
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosusArthritis & Rheumatism, 2008
- Budd-Chiari Syndrome Secondary to Antiphospholipid SyndromeMedicine, 2001